BEONE MEDICINES LTD. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount
BEONE MEDICINES LTD. (BEIGF) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount of $53.45 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-02-26
- BEONE MEDICINES LTD. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2024 was $53.45M, a 64.04% increase from fiscal 2023.
- BEONE MEDICINES LTD. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2023 was $32.58M, a 3.81% decline from fiscal 2022.
- BEONE MEDICINES LTD. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2022 was $33.87M.
- BEONE MEDICINES LTD. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2021 was -$27.41M.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month |
|---|---|
| 2024-12-31 | $53.45M 10-K · filed 2026-02-26 |
| 2023-12-31 | $32.58M 10-K · filed 2026-02-26 |
| 2022-12-31 | $33.87M 10-K · filed 2025-02-27 |
| 2021-12-31 | -$27.41M 10-K · filed 2024-02-26 |
| 2020-12-31 | -$22.03M 10-K · filed 2023-02-27 |
| 2019-12-31 | -$5.70M 10-K · filed 2022-02-28 |
| 2018-12-31 | -$5.37M 10-K · filed 2021-02-25 |
| 2017-12-31 | $1.99M 10-K · filed 2020-03-02 |
| 2016-12-31 | $0.00 10-K · filed 2019-02-28 |